Home » Newsletters » BioWorld Science

BioWorld Science

April 11, 2001

View Archived Issues

Traveler's diarrhea vaccine shows 100% efficacy in preclinical study

CeNeS reviews expanded product pipeline

3-D structure of GR determined as part of Karo Bio and Abbott collaboration

Enzo Biochem briefly updates products under development

Micro Therapeutics to begin pivotal U.S. clinical trial of Onyx LES for aneurysms

Dermik launches new eczema and psoriasis product in Canada

Roche files for E.U. approval of Xeloda/Taxotere combination for treatment of breast cancer

Following first launch, Levulan PDT now under evaluation for Barrett's esophagus

PRO-140 lowers viral load 20-fold in animal model of HIV

Isolation, structure elucidation and biological activity of new antitumor antibiotics

Novel antitubulin oxindole derivatives discovered during screening for antimitotic compounds

Benzimidazole carbamates as a new class of vascular targeting agents

AACR news: adenovirus-mediated RB94 gene therapy proven effective in preclinical tests

Expanded access program brings PEGASYS to hepatitis patients in Canada

Structure, in vivo activity of selective CDK1/CDK2 inhibitor revealed at ACS/AACR meetings

U.S. researchers design potent, advanced second-generation taxoids

FDA issues approvable letter for changes to Vioxx labeling

MGI Pharma and Helsinn sign definitive agreement for palonosetron

Pharmacyclics' Xcytrin enters phase II for primary brain tumors

Hemopure approved for the first time in South Africa

Neuroprotective fluorenone compounds from Questcor tested in vitro and in vivo

Merck presents new cell adhesion inhibitors and potential uses thereof

Novel compounds for influenza virus infections in the ViroPharma pipeline

Spiro compounds for eating or metabolic disorders disclosed by Banyu

Synthesis and biological evaluation of new 5-HT2A antagonists from Merck

Cephalon patents new kinase inhibitors

Broad-spectrum antibacterial macrocyclic compounds developed at Isis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...